Table 4.
Authors and year | Animal species | n | Graft type | Inner diameter of graft (mm) | Implantation model | Follow-up time (days) | Patency rate (%) |
---|---|---|---|---|---|---|---|
Shinoka et al. (1998)49 | Sheep | 7 | PGA/PLGA | 15 | Pulmonary artery interposition | 168 | 100 |
Niklason et al. (1999)51 | Pig | 4 | PGA | <6 | Right saphenous artery interposition | 24 | 100 |
Shum-Tim et al. (1999)66 | Sheep | 11 | PGA/PHA | 7 | Abdominal aorta interposition | 150 | 100 |
Watanabe et al. (2001)60 | Dog | 4 | Femoral vein cell-seeded PGA/PLCL | 10 | IVC interposition | 180 | 100 |
Izhar et al. (2001)75 | Dog | 8 | PELA | 6 | Carotid artery interposition | 90 | 100 |
Matsumura et al. (2003)57 | Dog | 16 | BMC-seeded PLCL | 8 | IVC interposition | 56 | 100 |
Iwai et al. (2004)56 | Dog | 20 | PLGA with collagen microsponge | 15 | Pulmonary artery patch | 180 | N/A |
Hibino et al. (2005)59 | Dog | 13 | Venous cell or bone marrow-seeded or unseeded PGA/PLCL | 8 | IVC interposition | 28 | 100 for seeded |
40% for unseeded | |||||||
Hoerstrup et al. (2006)67 | Sheep | 14 | PGA/PHA | 18 | Pulmonary artery interposition | 700 | 100 |
Matsumura et al. (2006)63 | Dog | 34 | BMC-seeded PGA/PLCL | 8 | IVC interposition | 180 | N/A |
Roh et al. (2007)61 | Sheep | 8 | BMVC-seeded PGA/PLCL | 13 | IVC interposition | 30 | 100 |
Brennan et al. (2008)50 | Sheep | 8 | PGA/PLCL | 13 | IVC interposition | 180 | 100 |
Torikai et al. (2008)54 | Pig | 15 | PGA/PLA | 10 | Thoracic aorta interposition | 360 | 100 |
Yokota et al. (2008)55 | Dog | 16 | PGA/PLA | 4 | Carotid artery and coronary artery bypass | 360 | 100 |
Zhang et al. (2008)64 | Dog | 16 | BMSC-seeded PGA/PLCL | 6 | Abdominal aorta interpostion | 90 | 100 |
Dahl et al. (2011)52 | Dog | 8 | PGA | 3–4 | Carotid artery and coronary artery bypass | 360 | 83 |
Cummings et al. (2012)69 | Sheep | 14 | Myofibroblast and EC-seeded PGA/PHA | — | Pulmonary artery interposition | 560 | 100 |
Kelm et al. (2012)68 | Sheep | 14 | PGA/PHA | 18 | Pulmonary artery interposition | 1680 | N/A |
Matsumura et al. (2013)62 | Dog | 7 | PGA/PLCL | 8 | Pulmonary artery interposition | 360 | 100 |
Wang et al. (2013)65 | Dog | 20 | Heparin-treated PLA/PLCL and polyurethane-collagen type I composite | <6 | Femoral artery interposition | 168 | 88.9 |
Lu et al. (2013)76 | Dog | — | Heparin-treated PCL | 2.5 | |||
Mrowczynski et al. (2014)53 | Pig | 11 | PCL | 4 | Carotid artery interposition | 30 | 78 |
Zhou et al. (2014)73 | Dog | 6 | EC-seeded PCL/CS | 3 | Carotid artery interposition | 90 | 83 |
Fukunishi et al. (2016)58 | Sheep | 6 | PCL/CS | 5 | Carotid artery interposition | 180 | 67 |
Fukunishi et al. (2016)58 | Sheep | 6 | PGA/PLCL | 12 | IVC interposition | 180 | 100 |
BMSC, bone marrow stromal cell; BMVC, bone marrow-derived vascular cells; CS, chitosan; IVC, inferior vena cava; PCL, poly ɛ-caprolactone; PELA, poly(ethylene glycol); PGA, polyglycolic acid; PHA, polyhydroxyalkanoate; PLA, polylactic acid; PLCL, poly (L-lactide-co-ɛ-caprolactone); PLGA, poly(lactic-co-glycolic acid).